Elizabeth L. Palavecino, MD
- Professor, Pathology
Elizabeth L. Palavecino, MD
Research Interests
- Antimicrobial Susceptibility Testing
- Molecular Diagnosis
- Education
- MD, Universidad de Chile, 1980
- Residency
- Universidad Catolica de Chile Graduate School, 1984
- Pathology, Case Western Reserve University, 1996
- Clinical Pathology, University Hospitals of Cleveland, 2002
- Fellowship
- Clinical Microbiology, University of Minnesota Medical School, 1992
- Transfusion Medicine, American Red Cross, 2003
- Board Certifications
- American Board of Pathology, Pathology-Anatomic/Pathology-Clinical
- American Board of Pathology, Blood Banking/Transfusion Medicine
- American Board of Pathology, Pathology-Clinical
- Memberships
- American Society of Microbiology
- Positions
- Director, Clinical Microbiology Laboratory
- Professor, Pathology
- Professor, Internal Medicine, Infectious Diseases
- Departments and Affiliations
- Clinical Microbiology Laboratory
- Pathology
- Internal Medicine, Infectious Diseases
- Office of Global Health
Research
- Laboratory approaches to determining blood culture contamination rates: an ASM Laboratory Practices Subcommittee report. Palavecino EL, Campodónico VL, She RC. J Clin Microbiol. 2024 Feb; 62(2):e0102823.
- In Vitro Activity of Omadacycline and Comparator Antibiotics against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Urinary Isolates. Stone TJ, Kilic A, Williamson JC, Palavecino EL. Antibiotics (Basel). 2023 May; 12(6)
- Potential of Inaccurate Cefiderocol Susceptibility Results: a CLSI AST Subcommittee Advisory. Simner PJ, Palavecino EL, Satlin MJ, Mathers AJ, Weinstein MP, Lewis JS, Humphries R. J Clin Microbiol. 2023 Apr; 61(4):e0160022.
- Evaluation of the combined use of the Sepsityper Kit with the Clearview PBP2a assay for identification of staphylococci strains and detection of their methicillin resistance directly from positive blood culture bottles. Kilic A, Palavecino E. J Med Microbiol. 2023 Feb; 72(2)
- Analytical evaluation of the cobas® 6800 system for the detection and quantification of BK Virus (BKV) and Epstein Barr Virus (EBV) at a US solid organ and hematopoietic stem cell transplant center. Palavecino EL, Ridley T, Hester L, Blosser SJ. Diagn Microbiol Infect Dis. 2023 Mar; 105(3):115884.